Lucid Announces Fourth Quarter and Full Year 2021 Financial Results, Updates 2022 Outlook
The Company's Q4 revenue was
"We are at the precipice of a global transition toward electric vehicles, and Lucid, with our leading technology and design, is at the forefront of one of the most significant transformations in mobility in generations," said
"Looking ahead, we're updating our outlook for 2022 production to a range of 12,000 to 14,000 vehicles. This reflects the extraordinary supply chain and logistics challenges we've encountered and our unrelenting focus on delivering the highest-quality products. We remain confident in our ability to capture the tremendous opportunities ahead given our technology leadership and strong demand for our cars," Rawlinson added.
Lucid will host a conference call for analysts and investors at
About
Lucid's mission is to inspire the adoption of sustainable energy by creating advanced technologies and the most captivating luxury electric vehicles centered around the human experience. The company's first car,
Forward Looking Statements
This communication includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as "estimate," "plan," "project," "forecast," "intend," "will," "expect," "anticipate," "believe," "seek," "target," "continue," "could," "may," "might," "possible," "potential," "predict" or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding financial and operating guidance, amount of reservations and related potential sales, future capital expenditures and other operating expenses, expectations and timing related to commercial product launches, production and delivery volumes, our estimate of the length of time our existing cash will be sufficient to fund planned operations, the timing of deliveries, future manufacturing capabilities and facilities, studio and service center openings, providing value to stakeholders, ability to mitigate supply chain risks and logistics, ability to vertically integrate production processes, future sales channels and strategies, future market launches and international expansion, including our planned manufacturing facility in
Non-GAAP Financial Measures and Key Business Metrics:
Consolidated financial information has been presented in accordance with US GAAP ("GAAP") as well as on a non-GAAP basis to supplement our consolidated financial results. Lucid's non-GAAP financial measures include Adjusted EBITDA and Free Cash Flow which are discussed below.
Adjusted EBITDA is defined as net loss and comprehensive loss before (1) interest expense, (2) provision for (benefit from) income taxes, (3) depreciation and amortization, (4) change in fair value of forward contracts, (5) change in fair value of convertible preferred stock warrant liability, (6) change in fair value of common stock warrant liability, (7) transaction costs expensed and (8) stock-based compensation. Adjusted EBITDA is a performance measure that Lucid believes provides useful information to Lucid's management and investors about Lucid's profitability. Free Cash Flow is defined as net cash used in operating activities less capital expenditures. Free Cash Flow is a performance measure that Lucid believes provides useful information to Lucid's management and investors about the amount of cash generated by the business after necessary capital expenditures.
These non-GAAP financial measures facilitate management's internal comparisons to Lucid's historical performance. Management believes that it is useful to supplement its GAAP financial statements with this non-GAAP information because management uses such information internally for its operating, budgeting, and financial planning purposes. Management also believes that presentation of the non-GAAP financial measures provides useful information to Lucid's investors regarding measures of our financial condition and results of operations that Lucid uses to run the business and therefore allows investors to better understand Lucid's performance. However, these non-GAAP financial and key performance measures have limitations as analytical tools and you should not consider them in isolation or as substitutes for analysis of our results as reported under GAAP.
Non-GAAP information is not prepared under a comprehensive set of accounting rules and therefore, should only be read in conjunction with financial information reported under GAAP when understanding Lucid's operating performance. In addition, other companies, including companies in our industry, may calculate non-GAAP financial measures and key performance measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of our non-GAAP financial measures and key performance measures as tools for comparison. A reconciliation between GAAP and non-GAAP financial information is presented below.
Investor Relations Contact
investor@lucidmotors.com
Media Contact
media@lucidmotors.com
|
||||
CONSOLIDATED BALANCE SHEETS1 |
||||
(in thousands, except share and per share data) |
||||
|
|
|||
ASSETS |
||||
Current assets: |
||||
Cash and cash equivalents |
$ 6,262,905 |
$ 614,412 |
||
Accounts receivable, net |
3,148 |
260 |
||
Short-term investments |
— |
505 |
||
Inventory |
127,250 |
1,043 |
||
Prepaid expenses |
70,346 |
21,840 |
||
Other current assets |
43,328 |
24,496 |
||
Total current assets |
6,506,977 |
662,556 |
||
Property, plant and equipment, net |
1,182,153 |
713,274 |
||
Right-of-use assets |
161,974 |
— |
||
Other noncurrent assets |
30,609 |
26,851 |
||
TOTAL ASSETS |
$ 7,881,713 |
$ 1,402,681 |
||
LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY |
||||
Current liabilities: |
||||
Accounts payable |
$ 41,342 |
$ 17,333 |
||
Accrued compensation |
32,364 |
16,197 |
||
Finance lease liabilities, current portion |
4,183 |
— |
||
Other current liabilities |
318,212 |
151,753 |
||
Total current liabilities |
396,101 |
185,283 |
||
Convertible preferred stock warrant liability |
— |
2,960 |
||
Finance lease liabilities, net of current portion |
6,083 |
— |
||
Common stock warrant liability |
1,394,808 |
— |
||
Long-term debt |
1,986,791 |
— |
||
Other long-term liabilities |
188,575 |
39,139 |
||
Total liabilities |
3,972,358 |
227,382 |
||
CONVERTIBLE PREFERRED STOCK |
||||
Convertible preferred stock, |
— |
2,494,076 |
||
STOCKHOLDERS' EQUITY (DEFICIT) |
||||
Preferred stock, par value |
— |
— |
||
Common stock, par value |
165 |
3 |
||
Additional paid-in capital |
9,995,778 |
38,113 |
||
|
(20,716) |
— |
||
Accumulated deficit |
(6,065,872) |
(1,356,893) |
||
Total stockholders' equity (deficit) |
3,909,355 |
(1,318,777) |
||
TOTAL LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' |
$ 7,881,713 |
$ 1,402,681 |
|
|||||||
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS1 |
|||||||
(in thousands, except share and per share data) |
|||||||
Three Months Ended |
Twelve Months Ended |
||||||
2021 |
2020 |
2021 |
2020 |
||||
Revenue |
$ 26,392 |
$ 3,634 |
$ 27,111 |
$ 3,976 |
|||
Costs and expenses |
|||||||
Cost of revenue |
151,473 |
2,520 |
154,897 |
3,070 |
|||
Research and development |
163,606 |
169,521 |
750,185 |
511,110 |
|||
Selling, general and administrative |
196,997 |
31,304 |
652,475 |
89,023 |
|||
Total cost and expenses |
512,076 |
203,345 |
1,557,557 |
603,203 |
|||
Loss from operations |
(485,684) |
(199,711) |
(1,530,446) |
(599,227) |
|||
Other income (expense), net: |
|||||||
Change in fair value of forward contracts |
— |
(109,663) |
(454,546) |
(118,382) |
|||
Change in fair value of convertible preferred stock warrant liability |
— |
(1,034) |
(6,976) |
(1,205) |
|||
Change in fair value of common stock warrant liability |
(557,973) |
— |
(582,760) |
— |
|||
Transaction costs expensed |
— |
— |
(2,717) |
— |
|||
Interest expense |
(1,263) |
(44) |
(1,374) |
(64) |
|||
Other (expense) income, net |
(742) |
(766) |
(893) |
(690) |
|||
Total other expense, net |
(559,978) |
(111,507) |
(1,049,266) |
(120,341) |
|||
Loss before provision for (benefit from) income taxes |
(1,045,662) |
(311,218) |
(2,579,712) |
(719,568) |
|||
Provision for (benefit from) income taxes |
18 |
57 |
49 |
(188) |
|||
Net loss and comprehensive loss |
(1,045,680) |
(311,275) |
(2,579,761) |
(719,380) |
|||
Deemed contribution related to repurchase of Series B convertible preferred stock |
— |
1,000 |
— |
1,000 |
|||
Deemed contribution related to repurchase of Series C convertible preferred stock |
— |
12,784 |
— |
12,784 |
|||
Deemed dividend related to the issuance of Series E convertible preferred stock |
— |
— |
(2,167,332) |
— |
|||
Net loss attributable to common stockholders |
$ (1,045,680) |
$ (297,491) |
$ (4,747,093) |
$ (705,596) |
|||
Weighted average shares outstanding used in computing net loss per share |
1,636,215,509 |
26,764,864 |
740,393,759 |
24,825,944 |
|||
Net loss per share attributable to common stockholders, basic and diluted |
$ (0.64) |
$ (11.11) |
$ (6.41) |
$ (28.42) |
|
|||
CONSOLIDATED STATEMENTS OF CASH FLOWS1 |
|||
(In thousands) |
|||
Year Ended |
|||
2021 |
2020 |
||
Cash flows from operating activities |
|||
Net loss |
$ (2,579,761) |
$ (719,380) |
|
Adjustments to reconcile net loss to net cash used in operating activities: |
|||
Depreciation and amortization |
62,907 |
10,217 |
|
Amortization of insurance premium |
18,474 |
— |
|
Non-cash operating lease cost |
12,563 |
— |
|
Stock-based compensation |
516,757 |
4,614 |
|
Loss on disposal of property and equipment |
52 |
139 |
|
Amortization of debt discount |
237 |
— |
|
Write-down of inventory |
48,884 |
— |
|
Change in fair value of contingent forward contract liability |
454,546 |
118,382 |
|
Change in fair value of preferred stock warrant liability |
6,976 |
1,205 |
|
Change in fair value of common stock warrant liability |
582,760 |
— |
|
Changes in operating assets and liabilities: |
|||
Accounts receivable |
(2,888) |
148 |
|
Inventory |
(175,091) |
(359) |
|
Financed insurance premium |
(41,935) |
— |
|
Prepaid expenses |
(25,045) |
7,770 |
|
Other current assets |
(14,704) |
7,360 |
|
Other noncurrent assets and security deposit |
5,889 |
2,866 |
|
Accounts payable |
4,354 |
(69,861) |
|
Accrued compensation |
16,167 |
13,249 |
|
Operating lease liability |
(10,019) |
— |
|
Other liabilities and accrued liabilities |
65,456 |
53,454 |
|
Other long-term liabilities |
(4,712) |
— |
|
Net cash used in operating activities |
(1,058,133) |
(570,196) |
|
Cash flows from investing activities: |
|||
Purchases of property, equipment, and software |
(421,220) |
(459,582) |
|
Proceeds from sale of short term investments |
505 |
— |
|
Proceed from sale of property, equipment, and software |
22 |
— |
|
Net cash used in investing activities |
(420,693) |
(459,582) |
|
Cash flows from financing activities: |
|||
Proceed from issuance of convertible notes, net of issuance costs |
2,002,437 |
— |
|
Payment of transaction costs for the issuance of convertible notes |
(15,883) |
— |
|
Payment for short-term insurance financing note |
(27,887) |
— |
|
Payment for capital lease liabilities |
— |
(364) |
|
Payment for finance lease liabilities |
(3,088) |
— |
|
Proceeds from short-term insurance financing note |
41,935 |
— |
|
Repurchase of Series B convertible preferred stock |
(3,000) |
— |
|
Repurchase of Series C convertible preferred stock |
— |
(12,101) |
|
Proceeds from issuance of Series D convertible preferred stock |
3,000 |
400,000 |
|
Proceeds from issuance of Series E convertible preferred stock |
600,000 |
899,725 |
|
Proceeds from exercise of stock options |
8,132 |
3,285 |
|
Proceeds from the exercise of public warrants |
173,273 |
— |
|
Proceeds from the reverse recapitalization |
4,439,153 |
— |
|
Payment of transaction costs related to the reverse recapitalization |
(38,865) |
— |
|
|
(20,716) |
— |
|
Stock repurchases from employees for tax withholdings |
(22,063) |
— |
|
Net cash provided by financing activities |
7,136,428 |
1,290,545 |
|
Net increase in cash, cash equivalents, and restricted cash |
5,657,602 |
260,767 |
|
Beginning cash, cash equivalents, and restricted cash |
640,418 |
379,651 |
|
Ending cash, cash equivalents, and restricted cash |
$ 6,298,020 |
$ 640,418 |
|
|||||||
Reconciliation of GAAP to Non-GAAP Financials Measures1 |
|||||||
Unaudited |
|||||||
(in thousands) |
|||||||
Adjusted EBITDA |
|||||||
Three Months Ended |
Twelve Months Ended |
||||||
2021 |
2020 |
2021 |
2020 |
||||
Net loss and comprehensive loss |
|
$ (311,275) |
|
$ (719,380) |
|||
Interest expense |
1,263 |
44 |
1,374 |
64 |
|||
Provision for (benefit from) income taxes |
18 |
57 |
49 |
(188) |
|||
Depreciation and amortization |
36,286 |
4,770 |
62,907 |
10,217 |
|||
Change in fair value of forward contracts |
— |
109,663 |
454,546 |
118,382 |
|||
Change in fair value of convertible preferred stock warrant liability |
— |
1,034 |
6,976 |
1,205 |
|||
Change in fair value of common stock warrant liability |
557,973 |
— |
582,760 |
— |
|||
Transaction costs expensed |
— |
— |
2,717 |
— |
|||
Stock-based compensation |
150,557 |
1,357 |
516,757 |
4,614 |
|||
Adjusted EBITDA |
$ (299,583) |
$ (194,350) |
$ (951,675) |
$ (585,086) |
Free Cash Flow |
||||||||
Three Months Ended |
Twelve Months Ended |
|||||||
2021 |
2020 |
2021 |
2020 |
|||||
Net cash used in operating activities (GAAP) |
(312,732) |
$ (192,789) |
|
$ (570,196) |
||||
Capital expenditures |
(121,907) |
(103,722) |
(421,220) |
(459,582) |
||||
Free cash flow (non-GAAP) |
$ (434,639) |
$ (296,511) |
|
|
___________________________________
1 The business combination (the "Merger") between
View original content:https://www.prnewswire.com/news-releases/lucid-announces-fourth-quarter-and-full-year-2021-financial-results-updates-2022-outlook-301491985.html
SOURCE